At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com **Job Function:** Career Programs **Job Sub** **Function:** Non-LDP Intern/Co-Op **Job Category:** Career Program **All Job Posting Locations:** Jakarta, Indonesia **Job Description:** We are recruiting for a **Supply Chain Intern** , located in Jakarta, Indonesia. As a Supply Chain Intern, you will be joining a diverse and dynamic environment as part of the Southeast Asia (SEA) supply chain team. In this role, you will gain six months of meaningful E2E supply chain experience, working alongside expert professionals, getting exposure to various SEA markets and assisting the team, focusing on continuous improvement projects and MAPE improvement. We are committed to helping our intern learn as much as you can about Supply Chain across SEA markets and build great foundational knowledge in the function. You will be responsible for: + Assisting the team in driving MAPE improvement + Participating in biweekly supply chain meetings + Supporting ongoing SEA supply chain projects + Assisting the planning team with various forecasting and analysis + Other ad-hoc tasks as assigned **Qualifications** + Currently a final year undergraduate or graduate student, majoring in Supply Chain Management, Engineering, or Statistics. Fresh graduates are also welcome to apply + Proficient in Excel and able to analyze complex data + Good command of English, written and spoken + Demonstrates strong learning agility, adaptability to change with a growth mindset + Able to commit for 6 months, with a planned start date as early as March 2025